Compounds · Immune · Immune system enhancement and viral infection treatment
Thymosin Alpha-1 (Zadaxin)
Zadaxin, Thymalfasin, TA1, Tα1
A synthetic 28-amino-acid peptide matching a natural thymic hormone, marketed as Zadaxin. It's an established immune modulator approved in many countries for hepatitis B and C, as a cancer-therapy adjuvant, and for immune-compromised patients. Since 2020, interest has grown in its use for COVID-19 and long COVID, boosting antitumor immunity in lung cancer, and for immune support in severe acute pancreatitis.
1.5 mg twice weekly
Research score 90/100. Reference only, not a prescription.
- Immune Boosting
- Anti-viral
- Anti-cancer
- Anti-inflammatory
- Inflammation Resolution
- US status
- Prescription Only
- Approval
- Approved in Some Countries
- Evidence
- Thymic peptide immunomodulator. Enhances T-cell function. Approved in many countries (not US) for Hepatitis B/C and as a vaccine adjuvant.
- Research score
- 90 / 100
- Indication
- Multiple Approved Indications
- Origin
- USA
- Source category
- Immune System
- Status group
- Approved / prescription
Mechanism
Binds Toll-like receptors TLR2 and TLR9 to drive T-cell maturation and Th1 cytokine output, raises MHC class I expression and dendritic-cell maturation, boosts NK-cell and antibody activity, and activates NF-κB and MyD88-dependent signaling to strengthen immune response against viruses and cancer while reducing inflammation.
Safety file
Excellent safety record; adverse events are rare and usually mild, such as injection-site reactions; no significant drug-related toxicity seen in large trials.
- Injection site reactions
- Mild fatigue
- Temporary flu-like symptoms
Reconstitution
| Vial | 2 mL water | 3 mL water |
|---|---|---|
| 10 mg | 5 mg/mL | 3.33 mg/mL |
- Use bacteriostatic water as the diluent.
- Add the water slowly, letting it run down the inside wall of the vial rather than onto the powder.
- Swirl gently to mix, then leave it to dissolve. Do not shake.
- Give it a few minutes. The finished solution should be clear and colourless.
Protocol
Route: Subcutaneous
Standard protocol (subcutaneous)
- 1.5 mg per dose (clinical studies use 1.6 mg)
- For general immune support, twice weekly
- When actively fighting something off, a short course of daily or twice-daily dosing is used
- At a 2 mL fill on a 10 mg vial (5 mg/mL), 1.5 mg is a 0.3 mL draw (30 units)
Course example
- The sepsis trial model was 1.6 mg twice daily for 5 days, then once daily for 2 days
- For everyday immune support, the lighter twice-weekly approach is more typical
Dosing detail
- Common dose is 1.5 mg (clinical 1.6 mg) per injection.
- Maintenance immune support: twice weekly. Acute short course: daily or twice daily for several days.
- An immune-modulating peptide.
- Generally well tolerated.
Duration
- Twice weekly for ongoing support, or a short daily course (around a week) when acutely needed.
Notes
- An immune-modulating peptide.
- Generally well tolerated.
- Inject subcutaneously and rotate sites.
Storage and handling
- Keep the powdered (lyophilized) vial in a cool, dark place. Refrigerate it for longer-term storage before mixing.
- Once reconstituted and refrigerated at 2–8 °C away from light, use the vial within 28 days.
- Do not freeze a reconstituted vial, and keep it away from heat and sunlight.
- If the solution turns cloudy, develops floating particles, or shows any other sign of degradation, stop using that vial.
NovaEvum vial
Worksheet
2 mL bacteriostatic water yields 5 mg/mL. A 1.6 mg draw is 32 units.
- Catalog fill
- 10 mg
- Typical water
- 2 mL
- Route
- Subcutaneous
- Cycle
- 4–8 weeks.
| Step | Amount | Frequency | Notes |
|---|---|---|---|
| Common research amount | 1.5–1.6 mg | Twice weekly | 30–32 units from a 2 mL reconstitution |
- Do not confuse with TB-500 (thymosin beta-4 fragment). The two are different molecules and different amounts.
- Bacteriostatic water: 20–25 °C. Do not refrigerate the diluent.
- Amounts on this sheet are reconstitution math for the vial, not a recommendation.